Industry
Pharmaceuticals
Topic
Mergers and Acquisitions
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Mergers and Acquisitions in Pharmaceuticals
... 2017 Lachute, Quebec Site will be Company's Fourth Advanced-Technology Production Facility TSX: ACB VANCOUVER, Nov. 23, 2017 /CNW/ - Aurora Cannabis Inc. (the "Company" or ...
... The acquisition of Simcro, which was announced earlier this year, could not be completed and the ...
... oncology program: Initiation of two additional Phase 1b/2 studies under collaboration with Genentech, following the first study which was initiated in July 2017. All studies ...
... September 30, 2016. The net loss for the quarter was due to Apicore's net loss for the quarter of $ 5.5 million. Medicure had net ...
... EST ORIGINAL ANNOUNCEMENT [Text] LAVAL, QC, Nov. 22, 2017 - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic) today announced positive interim six-month clinical ...
... Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company") (HKSE: 2633), a leading company engaged ...
... Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products ...
... announced the acquisition of Interleukin Genetics CLIA laboratory and their remaining assets. Interleukin Genetics' technology will become a core component of Orig3n's DNA test business ...
... federal securities laws by misrepresenting the benefits of the acquisition of Biotie Therapies Corporation ("Biotie"), specifically when referring to the tozadenant's approval prospects and commercial ...
... CanniMed Therapeutics Inc. ("CanniMed" or the "Company") (TSX:CMED) announced that it has formed a ...
... has provided a fairness opinion to the CanniMed Board of Directors. The Aurora Proposal On November 15, 2017, CanniMed issued a press release responding to ...
... September 30, 2016. The net loss for the quarter was due to Apicore's net loss for the quarter of $5.5 million. Medicure had net income ...
... Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today reported its ...
... Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based ...
... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, ...
... Capital, LLC announced today that it served as exclusive financial advisor to Nuun & Company on its growth equity financing from TSG Consumer Partners, LLC. ...
... CANADIAN DAILY STOCK REPORT Valeant Pharmaceuticals International, Inc. (TSX:VRX), Canada's largest Drug manufacturers company by market cap, extended its ...
... HAMPTON - Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today that enrollment has opened in its open-label ...
... WINNIPEG - Medicure Inc. ('Medicure' or the 'Company') (TSXV: MPH, OTC: MCUJF), a pharmaceutical company, today ...
... growth capital to successful mid-market companies, today announced the repayment by Medicure Inc. ('Medicure') (TSXV: MPH) of a special situations loan managed by Crown. Medicure ...
... BALTIMORE, MD - Cerecor Inc. (NASDAQ: CERC) and TRx Pharmaceuticals, LLC (TRx) today announced that the companies have entered into a purchase ...
... liver and inflammatory diseases, today announced that its previously majority owned subsidiary OphthaliX, Inc. (renamed Wize Pharma, Inc. (OTC Pink: WIZP)) has successfully completed a ...
... active pharmaceutical ingredients (“API”) business. The API business has been renamed from Perrigo API to Wavelength Pharmaceuticals (“Wavelength” or the “Business”). Wavelength is a leading ...
... ORIGINAL ANNOUNCEMENT [Text] Canada NewsWire VANCOUVER, Nov. 20, 2017 Provides Comments on CanniMed's Poison Pill Tactic Aurora's proposed offer currently valued at $24.00 per CanniMed ...
... growth capital to successful mid-market companies, today announced the repayment by Medicure Inc. ("Medicure") (TSXV: MPH) of a special situations loan managed by Crown. Medicure ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤